Apellis Pharmaceuticals Inc

APLS

Equity

ISIN null / Valor 30132056

NASDAQ (2026-02-25)

USD 21.42-3.21%

Apellis Pharmaceuticals Inc
UMushroom community rating:

3.00 1 votes No rating yet

NegativeNeutralPositive

About company

Apellis Pharmaceuticals Inc. is a biopharmaceutical company focused on developing therapies for autoimmune and inflammatory diseases through the inhibition of the complement system.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-20.4%1Y

-67.9%3Y

-52.5%5Y

Performance

67.0%1Y

72.5%3Y

71.3%5Y

Volatility

2710 M

Market cap (USD)

2,370,282

Daily traded volume (Shares)

32.49 / 31.89

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

3.00

1 votes

Performance:

4.00

Innovation:

3.00

Society:

3.00

Nature:

3.00

Petros Gakidis

Switzerland, 20 Mar 2022

EQUITIES OF THE SAME SECTOR

HealthEquity Inc

HealthEquity Inc Valor: 24679014

Annual Return

-50%0%+50%

Risk level

110

-0.43%USD 75.56

Laboratorios Farmaceuticos Rovi, SA

Laboratorios Farmaceuticos Rovi, SA Valor: 3591807

Annual Return

-50%0%+50%

Risk level

110

4.92%EUR 82.05

IVF HARTMANN Holding AG

IVF HARTMANN Holding AG Valor: 18762425

Annual Return

-50%0%+50%

Risk level

110

1.82%CHF 139.50

SHL Telemedicine Ltd

SHL Telemedicine Ltd Valor: 1128957

Annual Return

-50%0%+50%

Risk level

110

-0.93%CHF 1.06

Evolva Holding LTD

Evolva Holding LTD Valor: 126205578

Annual Return

-50%0%+50%

Risk level

110

7.54%CHF 0.97

Addex Therapeutics Ltd

Addex Therapeutics Ltd Valor: 2985075

Annual Return

-50%0%+50%

Risk level

110

3.73%CHF 0.05

Alnylam Pharmaceuticals Inc

Alnylam Pharmaceuticals Inc Valor: 1806798

Annual Return

-50%0%+50%

Risk level

110

-1.65%USD 327.36

MannKind Corp

MannKind Corp Valor: 35935511

Annual Return

-50%0%+50%

Risk level

110

-36.82%USD 3.50

BridgeBio Pharma Inc

BridgeBio Pharma Inc Valor: 48204826

Annual Return

-50%0%+50%

Risk level

110

-2.59%USD 66.54

Cassava Sciences Inc

Cassava Sciences Inc Valor: 46983284

Annual Return

-50%0%+50%

Risk level

110

-7.76%USD 2.26

Logos provided by Clearbit

Apellis Pharmaceuticals Inc

APLS

ISIN null / Valor 30132056

Apellis Pharmaceuticals Inc UMushroom community rating:

Petros Gakidis

Apellis Pharmaceuticals Inc
UMushroom community rating: